MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-AS-16-0014303
Syngex Pharma Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.41 Cr
▲ 40% YoY
Net profit · FY 2025
₹9.18 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹35.58 Lakh
EBITDA margin 5.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹3.29 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
20
Provident fund records
About Syngex Pharma Private Limited
Data last updated:
Syngex Pharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24100AS2018PTC018704. Its GSTIN is 18ABACS7629B1ZE (Assam).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ranjeet Baruah and Suman Das.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Devkata Nagar Paschim Boragaon Mikirghuli Guwahati, Assam, India – 781033.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.41 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹9.18 Lakh (net margin 1.4%) and EBITDA of ₹35.58 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years and 55% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.29 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Syngex Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0014303). For more details, the company can be reached via its website syngexpharma.com.
Company details
CIN U24100AS2018PTC018704
Registration Number 018704
Incorporation Date 05 September 2018
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-AS-16-0014303
Key People
Ranjeet Baruah Director Suman Das Director Recognitions & Rankings of Syngex Pharma
Contact details
Syngex Pharma Private Limited's registered office is in Guwahati, Assam. Its website is syngexpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDevkata Nagar Paschim Boragaon Mikirghuli Guwahati, Assam, India – 781033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Syngex Pharma Private Limited, buy the company report.
Comprehensive company report
Syngex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Syngex Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Syngex Pharma Private Limited, buy the company report.
Financials of Syngex Pharma Private Limited
FY 2024 filings availableSyngex Pharma Private Limited reported revenue of ₹6.41 Cr (up 40% YoY) for FY 2025.
Revenue · FY 2025
₹6.41 Cr ▲ 40%
Net profit · FY 2025
₹9.18 Lakh margin 1.4%
EBITDA · FY 2025
₹35.58 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 56%
5 years · compounded
▲ 55%
EBITDA CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 121%
5 years · compounded
▲ 88%
Revenue has grown at a compounded annual rate (CAGR) of 55% over five years, including 40% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Syngex Pharma Private Limited, buy the company report.
Board of directors of Syngex Pharma Private Limited
Syngex Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjeet Baruah | Director | 05 Sep 2018 | 8 Years 1 Months | Current |
| Suman Das | Director | 05 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Syngex Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Agency House (A&N Islands) Private Limited | ₹6.41 Cr (FY 2022) | -72.0% | Port Blair, Andaman and Nicobar Islands, India | |||
| Gadsco Industrial Enterprises Private Limited | ₹6.41 Cr (FY 2024) | 32.0% | Ludhiana, Punjab, India | |||
| Procyon Life Sciences Private Limited | ₹6.41 Cr (FY 2025) | -2.0% | Mumbai, Maharashtra, India | |||
| Suballiance Supply Chain Management Private Limited | ₹6.41 Cr (FY 2025) | 67.0% | Pune, Maharashtra, India | |||
| GMB Marbles Private Limited | ₹6.41 Cr (FY 2025) | 70.0% | Bhubaneswar, Odisha, India | |||
| Syngex Pharma Private Limitedthis company | ₹6.41 Cr (FY 2025) | ₹9.18 Lakh | 1.4% | 40.0% | 20 | Guwahati, Assam, India |
| Cosmo Texcorp Global Private Limited | ₹6.41 Cr (FY 2024) | 29.0% | Thane, Maharashtra, India | |||
| Nuorik Healthcare Private Limited | ₹6.41 Cr (FY 2025) | 34.0% | New Delhi, Delhi, India | |||
| Amsons Overseas Dyes & Chemicals Private Limited | ₹6.41 Cr (FY 2024) | 0.0% | Ludhiana, Punjab, India | |||
| One Microns Private Limited | ₹6.4 Cr (FY 2025) | 10.0% | Udaipur, Rajasthan, India | |||
| Relisys Solutions Private Limited | ₹6.4 Cr (FY 2024) | 98.0% | Delhi, India |
To see the full peer comparison of Syngex Pharma Private Limited, buy the company report.
Auditor
Syngex Pharma Private Limited is audited by KRISHNAKUMARPRAJAPATI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNAKUMARPRAJAPATI | FY 2023 | 312700 |
Shareholding
The shareholding of Syngex Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Syngex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.29 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2022 | 100600047 | Others | ₹3.29 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Syngex Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Alkem Laboratories Ltd | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Alkem Laboratories Ltd | Pending |
To see the full case history of Syngex Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syngex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Syngex Pharma Private Limited has a workforce of 20 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
20
Active EPFO establishments
1
Employee growth
66.67%
GST
Syngex Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18ABACS7629B1ZE | Assam | Active | 28 Sep 2018 |
To see the full GST registrations and return filing status of Syngex Pharma Private Limited, buy the company report.
Recent activity
Syngex Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ranjeet Baruah was appointed as Director on 05 Sep 2018.
AGM
Syngex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Syngex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati.
Charges
A charge with Others amounted to Rs. 3.29 Lakh with Charge ID 100600047 was registered on 31 May 2022.
Appointed
Ranjeet Baruah was appointed as Director.
Appointed
Suman Das was appointed as Director.
Incorporation
05 Sep 2018
Syngex Pharma Private Limited was registered on 05 Sep 2018 with Roc Guwahati & aged 8 years 1 month as per MCA records.
Frequently asked questions
Syngex Pharma is an active private limited company based in Guwahati, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 September 2018 (8+ years old) and is registered under CIN U24100AS2018PTC018704.
Syngex Pharma has 2 current directors:
- Ranjeet Baruah - Director
- Suman Das - Director
The latest financial statements of Syngex Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Syngex Pharma is 18ABACS7629B1ZE, registered in Assam.
The CIN (Corporate Identification Number) of Syngex Pharma is U24100AS2018PTC018704. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syngex Pharma has 2 court cases on record: 2 filed against it. 2 are pending.
Syngex Pharma was incorporated on 05 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Syngex Pharma by revenue are Agency House (A&N Islands) Private Limited, Gadsco Industrial Enterprises Private Limited, Procyon Life Sciences Private Limited, Suballiance Supply Chain Management Private Limited, GMB Marbles Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ranjeet Baruah was appointed as Director on 05 Sep 2018. Suman Das was appointed as Director on 05 Sep 2018.
Yes, Syngex Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-16-0014303).
Syngex Pharma can be reached through the website syngexpharma.com. Its registered office is in Guwahati, Assam, India.